Current awareness: Pharmacoepidemiology and drug safety
Quality circles to improve prescribing of primary care physicians. Three comparative studies† ‡
Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme
Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007†
The incidence of diabetes in atypical antipsychotic users differs according to agent—results from a multisite epidemiologic study†
Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs
Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection
Congenital abnormalities of 88 children born to mothers who attempted suicide with phenobarbital during pregnany: the use of a disaster epidemiological model for the evaluation of drug teratogenicity†
Time trends in the use of anti-hypertensive medications: results from the Multi-Ethnic Study of Atherosclerosis
NSAID use and risk of leukaemia: a population-based case-control study†
Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs†
Electrocardiographic monitoring for QT prolongation in patients treated with ziprasidone—A claims database approach†
Antiretroviral induced adverse drug reactions in Iranian human immunodeficiency virus positive patients†
Montelukast and psychiatric disorders in children†
Uses of proton pump inhibitors and serum potassium levels†